Therapeutic Area Expertise

Committed to advancing innovative therapies that make a meaningful difference in patients' lives.

From industry-firsts to well-researched indications, MMS brings a wealth of specialized knowledge across therapeutic areas to ensure that your drug development programs are supported by a team that truly understands the unique challenges and opportunities presented. We are proficient in a diverse range of therapeutic areas, including rare diseases, psychedelics, oncology and radiopharmaceuticals, central nervous system (CNS) disorders, and many others. Our deep understanding of these complex indications, combined with our data-driven approach and cutting-edge technology, allows us to be your trusted partner.

Whether you are pioneering new treatments for rare diseases, exploring the potential of psychedelics, or developing groundbreaking oncology therapies, MMS can bring your program to life through comprehensive solutions that focus on the long-term health of your project.

Review our therapeutic area expertise to understand how MMS can help you achieve your development goals across a variety of indications.

In addition to the pivotal therapeutic areas above, MMS global colleagues possess a depth and breadth of industry expertise that is unmatched in other areas.

Suggested For You

webinar

December 4th, 2025

Writing with Quality Control in Mind: A Cross-functional Approach 

webinar

June 26th, 2025

De-Risking Development with Specialized Data Strategies: From Trial Design to Submission

perspectives

November 4th, 2025

4 Key Takeaways from the EMA - Health Canada Joint Review Process and Evaluation of Its Efficiency

perspectives

October 28th, 2025

New Updates on Clinical Trial Transparency and Regulatory Requirements: A Comprehensive Overview 

webinar

October 21st, 2025

A Practical Guide to Expedited Regulatory Pathways

perspectives

October 21st, 2025

Shaping Clinical Development Through Writing: Francesca’s Journey at MMS 

news

October 16th, 2025

MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform 

perspectives

October 14th, 2025

CRO Partnerships and Biotech Agility: How Smaller Sponsors Gain Speed in Clinical Development  

perspectives

October 7th, 2025

From Academia to Building Medical Writing Partnerships: Jessica Murdock’s MMS Story  

news

October 2nd, 2025

MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases

perspectives

September 30th, 2025

Ready by Design: Endpoints, Feasibility, and Scenario Testing

news

September 24th, 2025

MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers